Updated Jul 16, 2026
Cox Christopher Nixon has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Christopher Nixon Cox is listed as a director of Alto Neuroscience, Inc. in SEC filings with the most recent filing date of 2026-05-14. Public sources within the SEC filing context identify him in the role of director for Alto Neuroscience, but there is limited verifiable public information about his broader professional background available in widely cited sources. As of the filing date, there is no public record indicating his death.
| Role | Director |
|---|---|
| Notability | 20/100 |
Christopher Nixon Cox is listed as a director of Alto Neuroscience, Inc. in SEC filings with the most recent filing date of 2026-05-14. Public sources within the SEC filing context identify him in the role of director for Alto Neuroscience, but there is limited verifiable public information about his broader professional background available in widely cited sources. As of the f…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cox Christopher Nixon profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.